Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Abstract:

:Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) usually affect adults and older populations. The well recognized clinical (i.e., granulomatosis with polyangiitis [GPA], microscopic polyangiitis, and eosinophilic GPA) and serological phenotypes (i.e., anti-MPO-ANCA, anti-PR3-ANCA and ANCA negative) within AAV differ substantially for clinical, demographic, and epidemiological features, including age at presentation. Whether and how aging could contribute to the clinical expression of these disease phenotypes is intriguing and still overlooked. In addition, despite being predominantly a disease of the elderly, most of the studies analyzing drug interventions and the clinical trials on AAV explicitly excluded older patients, limiting the understanding of the disease in this subset of patients. In elderly patients induced with cyclophosphamide, a lower dose of treatment for patients aged 60 years or older and with reduced renal function has been recommended. Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are two primary systemic vasculitides involving large vessels that differ in age at presentation, with GCA patients being at least 10 years older than TAK patients. Different treatment approaches are effective in these conditions. However, a few authors have suggested that they might be considered expressions of the same clinical syndrome, rather than two different diseases. Novel insights into the role of senescence-related immunological and vascular processes might help to interpret the link between these two conditions. Overall, the impact of aging on all these vasculitides is complex and not easy to analyze. So far, few studies focusing on this topic have been published. We reviewed data on the clinical presentation, epidemiology, therapy, and disease- and treatment-related complications in patients affected by these vasculitides, highlighting the differences in young versus elderly subjects.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Berti A,Caporali R,Montecucco C,Paolazzi G,Monti S

doi

10.1007/s40266-018-0617-4

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

53-63

issue

1

eissn

1170-229X

issn

1179-1969

pii

10.1007/s40266-018-0617-4

journal_volume

36

pub_type

杂志文章,评审
  • Issues in the perioperative management of the elderly patient with cardiovascular disease.

    abstract::The elderly patient may show normal physiological changes of the cardiovascular and respiratory systems that accompany aging, as well as features of intrinsic cardiac disease. The latter include: a past history of myocardial infarction or ischaemic heart disease; history of congestive cardiac failure; angina; arterial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219060-00003

    authors: Sear JW,Higham H

    更新日期:2002-01-01 00:00:00

  • Understanding patient compliance and persistence with osteoporosis therapy.

    abstract::Chronic non-terminal diseases, including postmenopausal osteoporosis, are associated with poor treatment compliance and persistence. The longer a patient with osteoporosis complies and persists with treatment, the lower the risk of fracture. Retrospective studies with emphasis on real-world data have led to a greater ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11586880-000000000-00000

    authors: Gold DT

    更新日期:2011-04-01 00:00:00

  • Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke?

    abstract:BACKGROUND:Since 1998, a prospective payment system (PPS) for Medicare services provided by nursing homes in the US has been in operation. Concerns have been expressed that the PPS may affect the quality of care delivered to residents. This study evaluates the impact of the PPS on pharmacological secondary ischaemic st...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200623010-00006

    authors: Lapane KL,Hughes CM

    更新日期:2006-01-01 00:00:00

  • Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study.

    abstract:BACKGROUND:Medication-related problems are common in the growing population of older adults and inappropriate prescribing is a preventable risk factor. Explicit criteria such as the Beers criteria provide a valid instrument for describing the rate of inappropriate medication (IM) prescriptions among older adults. OBJE...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11584770-000000000-00000

    authors: Blozik E,Born AM,Stuck AE,Benninger U,Gillmann G,Clough-Gorr KM

    更新日期:2010-12-01 00:00:00

  • Influenza vaccination and the elderly: pandemic preparedness.

    abstract::Seasonal influenza causes significant morbidity and mortality in the elderly, the very young and those with chronic illness, despite the availability of effective vaccines. The mortality and morbidity attributed annually to seasonal influenza are small in comparison to the potential mortality and morbidity of a novel ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825030-00001

    authors: Kasten MJ,Poland GA

    更新日期:2008-01-01 00:00:00

  • Diagnosis and treatment of patients with severe Alzheimer's disease.

    abstract::In contrast with the earlier stages and, in particular, the predementia stage, of Alzheimer's disease (AD), severe dementia is often neglected. However, the advanced stages of dementia are just as important as the earlier stages because of their frequency, their impact on the lives of patients and their caregivers, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/0002512-200926020-00005

    authors: Voisin T,Vellas B

    更新日期:2009-01-01 00:00:00

  • Current recommendations for the prevention and treatment of influenza in the older population.

    abstract::Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be enc...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101060-00003

    authors: Gross PA

    更新日期:1991-11-01 00:00:00

  • Age-related changes in male gonadal function. Implications for therapy.

    abstract::In contrast with women, who experience a complete and abrupt cessation of ovarian function during the menopause, aging men largely maintain their testicular androgen production. Nevertheless, most cross-sectional studies indicate that there is a partial decrease in testosterone levels with aging, although this has not...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711010-00005

    authors: Maas D,Jochen A,Lalande B

    更新日期:1997-07-01 00:00:00

  • The Internet as an information source for geriatricians.

    abstract::Electronic storage of and access to medical data is becoming increasingly common. Advances in computer technology and telecommunications have made it possible to store vast amounts of information in databases and transmit this information rapidly to any place on the globe. At the forefront of this technology is the In...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710030-00001

    authors: Glowniak J

    更新日期:1997-03-01 00:00:00

  • Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

    abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711040-00006

    authors: Foster RH,Balfour JA

    更新日期:1997-10-01 00:00:00

  • Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults.

    abstract::Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV13; Prevenar 13(®); Prevnar 13(®)) is approved in adults aged ≥50 years (focus of review) and in children aged 6 weeks to 5 years for protection against pneumococcal diseases caused by Streptococcus pneumoniae in numerous countries worldwide, incl...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-012-0017-0

    authors: Scott LJ,Sanford M

    更新日期:2012-10-01 00:00:00

  • Treating asthma in the older patient: is there a place for leukotriene modifiers?

    abstract::Asthma is a common airway disease found in people of all ages, although most studies of asthma therapies are focused on adolescent and young adults. Little information exists on the use of asthma therapeutics in the older patient (>65 years of age). The newest therapeutic class to be released in the US for the treatme...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200623060-00002

    authors: Grayson MH,Korenblat PE

    更新日期:2006-01-01 00:00:00

  • Treatment of Seizures in Older Patients with Dementia.

    abstract::The numbers of patients with dementia and patients with epilepsy are increasing in the global population. In fact, these two conditions are related, and it is estimated that at least 5-10% of seizures or epilepsy in older individuals (aged > 60 years) are caused by a neurodegenerative dementia. In the vast majority, o...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00826-2

    authors: Cretin B

    更新日期:2020-12-14 00:00:00

  • Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

    abstract::Giant cell arteritis (GCA) is an inflammatory vasculopathy that involves large- and medium-sized arteries and can cause vision loss, stroke and aneurysms. GCA occurs in people aged >50 years and is more common in women. A higher incidence of the disease is observed in populations from Northern European countries. Poly...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11592500-000000000-00000

    authors: Schmidt J,Warrington KJ

    更新日期:2011-08-01 00:00:00

  • Current management strategies for hepatitis B in the elderly.

    abstract::Despite the availability of an efficient vaccine, chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide. The World Health Organization estimates that there are still 350 million chronic carriers of the virus who are at risk of developing chronic hepatitis, liver cirrhosis and hepato...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118100-00002

    authors: Merle P,Trépo C,Zoulim F

    更新日期:2001-01-01 00:00:00

  • Anaesthesia for cataract surgery.

    abstract::Cataract surgery is the most frequent surgical procedure requiring anaesthesia in developed countries. It is performed mainly in elderly patients, who present with many coexisting diseases that induce subsequent hazards from general anaesthesia. Cataract anaesthesia is performed following various techniques of regiona...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11318590-000000000-00000

    authors: Nouvellon E,Cuvillon P,Ripart J,Viel EJ

    更新日期:2010-01-01 00:00:00

  • Optimal pharmacotherapeutic management of acute lymphoblastic leukaemia in the elderly.

    abstract::The main characteristic of acute lymphoblastic leukaemia (ALL) in the elderly is its dismal prognosis. However, other than a lower incidence of T-cell ALL and a greater likelihood of unfavourable chromosomal abnormalities, the clinical and biological characteristics of Philadelphia chromosome-negative (Ph-) ALL in the...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11592850-000000000-00000

    authors: Rousselot P,Delannoy A

    更新日期:2011-09-01 00:00:00

  • Vitreous haemorrhage in elderly patients: management and prevention.

    abstract::Vitreous haemorrhage can be caused by a disruption of normal retinal vessels, bleeding from diseased retinal vessels, bleeding from abnormal new vessels or extension of haemorrhage through the retina from other sources. In the elderly, vitreous haemorrhage usually occurs spontaneously and only occurs occasionally as a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320090-00003

    authors: Manuchehri K,Kirkby G

    更新日期:2003-01-01 00:00:00

  • The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

    abstract::Nitric oxide (NO) is involved in important physiological functions of the CNS, including neurotransmission, memory and synaptic plasticity. Depending on the redox state of NO, it can act as a neurotoxin or it can have a neuroprotective action. Data suggest that NO may have a role in the pathogenesis of neurodegenerati...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199812040-00001

    authors: Molina JA,Jiménez-Jiménez FJ,Ortí-Pareja M,Navarro JA

    更新日期:1998-04-01 00:00:00

  • Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study.

    abstract::High drug consumption among the elderly and inappropriate prescribing practices increase the risk of adverse drug effects in this population. This risk may be decreased by conducting, for example, a medication review alone or as part of a comprehensive geriatric assessment (CGA); however, little is known about the fat...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.2165/11536650-000000000-00000

    authors: Lampela P,Hartikainen S,Lavikainen P,Sulkava R,Huupponen R

    更新日期:2010-06-01 00:00:00

  • Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

    abstract::Parkinson's disease (PD) is a chronic movement disorder typically coupled to progressive degeneration of dopaminergic neurons in the substantia nigra (SN). The treatments currently available are satisfactory for symptomatic management, but the efficacy tends to decrease as neuronal loss progresses. Neurotrophic factor...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-014-0160-x

    authors: Rodrigues TM,Jerónimo-Santos A,Outeiro TF,Sebastião AM,Diógenes MJ

    更新日期:2014-04-01 00:00:00

  • Pharmacological Treatment of Post-Prostatectomy Incontinence: What is the Evidence?

    abstract::Urinary incontinence is a common and debilitating problem, and post-prostatectomy incontinence (PPI) is becoming an increasing problem, with a higher risk among elderly men. Current treatment options for PPI include pelvic floor muscle exercises and surgery. Conservative treatment has disputable effects, and surgical ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-016-0388-8

    authors: Løvvik A,Müller S,Patel HR

    更新日期:2016-08-01 00:00:00

  • Molecular rationale for the pharmacological treatment of Alzheimer's disease.

    abstract::Cerebral deposition of amyloid plaques containing amyloid beta-peptide (Abeta) has traditionally been considered the central feature of Alzheimer's disease (AD). Abeta is derived from amyloid precursor protein (APP), which is cleaved by several different proteases: alpha-, beta- and gamma-secretase. In the past decade...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522001-00003

    authors: Zimmermann M,Gardoni F,Di Luca M

    更新日期:2005-01-01 00:00:00

  • Drug treatment of pneumococcal pneumonia in the elderly.

    abstract::Streptococcus pneumoniae has been recognised as a major cause of pneumonia since the time of Sir William Osler. Drug-resistant S. pneumoniae (DRSP), which have gradually become resistant to penicillins as well as more recently developed macrolides and fluoroquinolones, have emerged as a consequence of indiscriminate u...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421130-00003

    authors: Neralla S,Meyer KC

    更新日期:2004-01-01 00:00:00

  • Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

    abstract::Alzheimer's disease is the most common major neurocognitive disorder with substantial social and economic impacts. This article is an update on current pharmacotherapy, advancements in biomarker use, and drugs in the pipeline for this disease. To date, no new drug has qualified to be added to the current therapeutic a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0499-x

    authors: Khoury R,Patel K,Gold J,Hinds S,Grossberg GT

    更新日期:2017-11-01 00:00:00

  • Effect of antihypertensive agents on quality of life in the elderly.

    abstract::Management of hypertension in the elderly should take into account, in particular, the possible negative impact of antihypertensive drugs on the patient's quality of life, the deterioration of which may result in a loss of independence and reduced treatment compliance. Quality of life is recognised as a multifactorial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421060-00003

    authors: Fogari R,Zoppi A

    更新日期:2004-01-01 00:00:00

  • Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma.

    abstract:BACKGROUND:Glaucoma comprises age-related neurodegenerative diseases of retinal ganglion cells, the worldwide prevalence of which is increasing. Local pharmacotherapy is the primary treatment option, especially in the elderly. But this therapeutic approach may include risks for adverse drug effects and drug-drug intera...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-012-0036-x

    authors: Huber M,Kölzsch M,Stahlmann R,Hofmann W,Bolbrinker J,Dräger D,Kreutz R

    更新日期:2013-01-01 00:00:00

  • Severity and management of drug-drug interactions in acute geriatric patients.

    abstract:BACKGROUND:Previous studies have investigated the prevalence of drug-drug interactions (DDIs) among the elderly in different care settings, but data describing the frequency and management of DDIs among acute geriatric patients appear to be absent. OBJECTIVE:The aim of this study was to investigate the severity and in...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0091-y

    authors: Lea M,Rognan SE,Koristovic R,Wyller TB,Molden E

    更新日期:2013-09-01 00:00:00

  • Adverse effects of clozapine in older patients: epidemiology, prevention and management.

    abstract::Research into the use of clozapine in older people is somewhat scarce. Clozapine is associated with serious adverse effects such as agranulocytosis, seizures, myocarditis and metabolic syndrome. Other common undesirable effects such as sedation, constipation (which can be fatal), urinary incontinence and hypersalivati...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-013-0144-2

    authors: Bishara D,Taylor D

    更新日期:2014-01-01 00:00:00

  • Acute cough in the elderly: aetiology, diagnosis and therapy.

    abstract::Although the frequency of physician consultations and the sale of over-the-counter remedies establish the high prevalence of acute cough in the elderly, epidemiological studies have tended to be imprecise. However, respiratory tract infections in nose, larynx and/or bronchi, either viral or bacterial or both, are by f...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421040-00003

    authors: Widdicombe J,Kamath S

    更新日期:2004-01-01 00:00:00